オプションチェーンは、Ivanhoe Electricの株式オプションの主要データを様々な行使価格と満期日で表示します。トレーダーはこの情報を使用して、潜在的な取引を分析し、Ivanhoe Electricの市場センチメントを評価します。.

Ivanhoe Electric (AMEX:IE) 株価情報, オプションチェーン

Ivanhoe Electric

Ivanhoe Electric Inc is a United States-based d minerals exploration company with a focus on developing mines from mineral deposits principally located in the United States. The company has four business segments; Santa Cruz Project; critical metals; data processing services; and energy storage. It derives a majority of its revenue from Canada. The Santa Cruz Project and critical metals segments are focused on mineral project exploration and development. The data processing segment provides data analytics, geophysical modeling, and artificial intelligence services for the mineral, oil & gas, and water exploration industries. The energy storage segment develops, manufactures, and installs vanadium flow batteries for grid-scale energy storage.

Ivanhoe Electric Inc

INDUSTRIAL ENTRPS AMERICA by Industrial Enterprises of America, Inc.

INTRA ENERGY CORP LTD by INTRA ENERGY CORPORATION LTD

iShares U.S. Consumer Focused ETF

iShares 7-10 Year Treasury Bond ETF

iShares Core MSCI EAFE ETF

INDEPENDENCE GOLD CORP by Independence Gold Corp.

Independence Gold Corp

IEH Corp

iShares 3-7 Year Treasury Bond ETF

iShares Core MSCI Emerging Markets ETF

IENTERTAINMENT NTWRK INC by iEntertainment Network, Inc.

iEntertainment Network Inc

iShares U.S. Oil & Gas Exploration & Production ETF

Icahn Enterprises L.P. - Depositary Units representing Limited Partner Interests

Icahn Enterprises LP

IES Holdings Inc

INTERCONEXION ELEC S/ADR by Interconexion Electrica S.A. E.S.P. - ISA

Interconexion Electrica SA ESP

INVINITY ENERGY SYS PLC by Invinity Energy Sys Plc.

Invinity Energy Systems PLC

iShares U.S. Tech Independence Focused ETF

iShares Core MSCI Europe ETF

iShares MSCI Europe Small-Cap ETF

iShares Europe ETF

IDEX Corp

iExalt Inc

iShares U.S. Oil Equipment & Services ETF

Citigroup analyst Anthony Pettinari maintains Ferguson Enterprises (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FERG#NYSE">FERG</a>) with a Neutral and lowers the price target from $189 to $168.

News

Price Target

Analyst Ratings

FERG

Citigroup Maintains Neutral on Ferguson Enterprises, Lowers Price Target to $168

UnitedHealth Group's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>) short percent of float has risen 10.47% since its last report. The company recently reported that it has 8.69 million shares sold short, which is 0.95% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.14 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>UnitedHealth Group Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1741804233_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for UnitedHealth Group has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing UnitedHealth Group's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, UnitedHealth Group's peer group average for short interest as a percentage of float is 5.11%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Trading Ideas

Peering Into UnitedHealth Group's Recent Short Interest

Global E Online's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLBE#NYSE">GLBE</a>) short percent of float has fallen 16.89% since its last report. The company recently reported that it has 3.56 million shares sold short, which is 3.69% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.22 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Global E Online Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1741804226_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Global E Online has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Global E Online's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Global E Online's peer group average for short interest as a percentage of float is 11.08%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

GLBE

Is Global E Online Gaining or Losing Market Support?

Valmont Industries's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VMI#NYSE">VMI</a>) short percent of float has risen 46.73% since its last report. The company recently reported that it has 442 thousand shares sold short, which is 2.92% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.37 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Valmont Industries Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1741804220_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Valmont Industries has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Valmont Industries's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Valmont Industries's peer group average for short interest as a percentage of float is 5.92%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Is the Market Bullish or Bearish on Valmont Industries?

- Bloomberg News
&nbsp;
&nbsp;
<a href="https://www.bloomberg.com/news/articles/2025-03-12/drugmakers-mallinckrodt-and-endo-are-in-talks-to-merge" title="https://www.bloomberg.com/news/articles/2025-03-12/drugmakers-mallinckrodt-and-endo-are-in-talks-to-merge">https://www.bloomberg.com/news/articles/2025-03-12/drugmakers-mallinckrodt-and-endo-are-in-talks-to-merge</a>

NDOI

Drugmakers Mallinckrodt And Endo Are In Talks To Merge That Could Be Valued At About $7B

WIIM

CENX

STLD

Shares of steel and aluminum stocks are trading higher amid US steel and aluminum tariffs.

Citigroup analyst Paul Lejuez maintains Dick's Sporting Goods (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DKS#NYSE">DKS</a>) with a Neutral and lowers the price target from $230 to $220.

Citigroup Maintains Neutral on Dick's Sporting Goods, Lowers Price Target to $220

Citigroup analyst Keith Horowitz maintains Regions Finl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RF#NYSE">RF</a>) with a Buy and lowers the price target from $30 to $28.

Citigroup Maintains Buy on Regions Finl, Lowers Price Target to $28

&nbsp;<a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4381996-1&amp;h=1846396181&amp;u=http%3A%2F%2Fwww.vuzix.com%2Fhome%2F&amp;a=Vuzix%C2%AE+Corporation">Vuzix&#xAE; Corporation</a>&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VUZI#NASDAQ">VUZI</a>), ("Vuzix" or, the "Company"), a leading supplier of AI driven smart glasses, waveguides and augmented reality (AR) technologies, today announced that Xander&#x2122;, a Raleigh, North Carolina-based company, has placed its largest re-order to date for Vuzix Shield&#x2122; smart glasses. This order supports the increasing customer demand for the XanderGlasses&#x2122; solution, a product and software offering that provides real-time captions to assist people with auditory disorders.
XanderGlasses utilize Vuzix Shield smart glasses and are ready to go out of the box. Just push a button, put the glasses on, and you'll see real-time captions of what other people are saying in conversations — directly in the user's field of view, facilitating seamless communication for individuals with hearing challenges. XanderGlasses are 100% self-contained, designed for ease of use, they operate with a simple 'on' and 'off' function and do not require a smartphone or cloud connectivity, ensuring reliability and privacy. This makes them suitable for various environments, including home, work, and public spaces. The lenses have full UV protection, and meet the highest safety standards, ANSI Z87.1 certification.
"With 48 million people in the U.S. experiencing hearing loss, a number that continues to rise, XanderGlasses empower individuals to 'see' what others are saying," explains Alex Westner, Co-Founder and CEO of Xander. "Our team has worked closely with individuals at all stages of hearing loss to develop a simple and reliable solution that meets real-world needs."

VUZI

Vuzix Announces Re-Order From Xander For Vuzix Shield Smart Glasses To Support Demand For XanderGlasses Solution

DailyDelta officially stepped into the <a href="https://www.benzinga.com/etfs">ETF market </a>with the launch of two new funds: the DailyDelta Q100 Upside Option Strategy ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/QUP#NYSE">QUP</a>) and the DailyDelta Q100 Downside Option Strategy ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/QDWN#NYSE">QDWN</a>). 
With these ETFs, investors can track the Nasdaq-100 Index&#8217;s daily fluctuations while finding opportunities to profit from market movements in both directions.
Investors seeking gains from daily Nasdaq-100 downturns can find QDWN ideal as it follows the performance of the top 100 nonfinancial Nasdaq-listed companies. The fund seeks to replicate the negative performance of the index while restricting daily losses to a maximum of 10% of its net asset value. 
The fund gains from Nasdaq-100 declines through its primary investment in cash-settled index put options which deliver cash instead of stocks. To protect against the rapid expiration of its put options which can last as little as one trading day, QDWN keeps about 90% of its assets invested in short-term U.S. Treasury securities.
Also Read: <a href="https://www.benzinga.com/25/03/44259396/short-term-bond-etfs-see-record-inflows-amid-market-turmoil-3-funds-that-led-the-surge">Short-Term Bond ETFs See Record Inflows Amid Market Turmoil: 3 Funds That Led The Surge</a>
QUP targets investors seeking daily performance benefits from Nasdaq-100 index movements. The fund aims to boost index gains while ensuring daily losses do not exceed 10%. It achieves this goal by purchasing cash-settled call options, which supply leveraged exposure to upward movements in the index.
QUP and QDWN both come with an expense ratio of 1.35%.
The ongoing concern about market volatility is leading to an increased demand for investment strategies that effectively manage daily fluctuations. DailyDelta already registered several new ETFs targeting the Russell 2000 Index and S&amp;P 500 Index in a recent filing. The upcoming funds include:
<ul>
<li>DailyDeltaTM SP500 Upside Option Strategy ETF (SXUP)</li>
<li>DailyDeltaTM SP500 Downside Option Strategy ETF (SDWN)</li>
<li>DailyDeltaTM R2000 Upside Option Strategy ETF (RUP)</li>
<li>DailyDeltaTM R2000 Downside Option Strategy ETF (RDWN)</li>
</ul>
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/etfs/new-etfs/25/03/44281017/new-etf-balances-sp-500-exposure-with-treasury-stability-to-limit-losses">New ETF Balances S&amp;P 500 Exposure With Treasury Stability To Limit Losses</a></li>
</ul>
Photo: T. Schneider via Shutterstock

New ETFs

ETFs

QDWN

DailyDelta Rolls Out ETFs For Daily Nasdaq-100 Index Movements

Citigroup analyst Tyler Radke maintains Oracle (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORCL#NYSE">ORCL</a>) with a Neutral and lowers the price target from $194 to $160.

ORCL

Citigroup Maintains Neutral on Oracle, Lowers Price Target to $160

Traders found relief in a cooler-than-expected inflation report, driving tech-heavy indices to a rebound on Wednesday <a href="https://www.benzinga.com/economics/macro-economic-events/25/03/44274165/inflation-cools-more-than-expected-in-february-strengthens-the-case-for-fed-rate-cuts">despite ongoing trade tensions.</a>
In February, the Consumer Price Index declined from 3% year-over-year to 2.8%, beating analysts' expectations of a slowdown to 2.9%. Core inflation also dropped more than anticipated, easing from 3.3% to 3.1%.
The decline was supported by contractions in key categories, with gasoline prices falling 1% month-over-month and transportation costs down 0.8%. Airline fares saw a sharper drop, contracting by 4%.
The softer inflation data strengthened expectations for Federal Reserve rate cuts, with traders now assigning nearly an 80% probability of a reduction by June, according to CME's FedWatch Tool.
While inflation relief fueled optimism, trade concerns lingered. The U.S. imposed 25% tariffs on steel and aluminum in April, prompting swift retaliation. In response, the EU introduced tariffs on €26 billion worth of U.S. goods, while Canada imposed additional levies on $29.8 billion, supplementing previous penalties.
The S&amp;P 500 rose 0.6%, while the Nasdaq 100 jumped 1.2%, aiming to break a two-session losing streak. In contrast, the Dow remained flat. 
Tech stocks led the rebound from their recent sell-off, with Palantir Technologies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NASDAQ">PLTR</a>), Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>), and Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) rallying 6.2%, 6.4%, and 7.5%, respectively.
Treasury yields remained flat on the day, while gold climbed 0.8% to $2,940 per ounce, now just 0.5% below its all-time high.
Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) edged down 0.8%.
<h2 class="wp-block-heading">Wednesday&#8217;s Performance In Major US Indices</h2>
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Major Indices</td>
<td>Price</td>
<td>%</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>19,625.52</td>
<td>1.3%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>5,606.41</td>
<td>0.6%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>2,027.44</td>
<td>0.3%</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>41,428.96</td>
<td>0.0%</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption">Updated at 1:15 p.m. ET</figcaption></figure>
According to&nbsp;<a href="https://www.benzinga.com/pro/?utm_source=BZprocontent&amp;t=be2bearmibe3na1" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>&nbsp;data:
<ul>
<li>The&nbsp;SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) rose 0.7% to $560.14.</li>
<li>The&nbsp;SPDR Dow Jones Industrial Average&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>) flattened at $414.65.</li>
<li>The tech-heavy&nbsp;Invesco QQQ Trust Series&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>)&nbsp;rose 1.4% to $478.01.</li>
<li>The&nbsp;iShares Russell 2000 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWM#NYSE">IWM</a>) inched 0.2% higher to 201.20. </li>
<li>The&nbsp;Technology&nbsp;Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLK#NYSE">XLK</a>) outperformed, up 1.8%; the&nbsp;Consumer Staples&nbsp;Select Sector SPDR Fund&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLP#NYSE">XLP</a>)&nbsp;was the worst sector performer, down 1.9%.</li>
</ul>
<h2 class="wp-block-heading">Wednesday&#8217;s Stock Movers</h2>
<ul>
<li>American Airlines Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAL#NASDAQ">AAL</a>) tumbled 3.7%, eyeing its tenth negative session over the past eleven as the company issued a negative outlook for the quarter. Meanwhile, Bank of America lowered the stock price target from $19 to $13. </li>
<li>United Airlines Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UAL#NASDAQ">UAL</a>) dropped 4.2% after a wave of price target cuts from major banks. Barclays lowered its target from $150 to $140, BofA trimmed it from $125 to $110, and TD Cowen reduced its estimate from $165 to $150.</li>
<li>Intel Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>) surged 4.6% after a Reuters report revealed that Taiwan Semiconductor Manufacturing Company Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>) had approached Nvidia, Advanced Micro Devices Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>), and Broadcom Inc. about investing in a joint venture to operate Intel&#8217;s factories.</li>
</ul>
Read now: 
<ul>
<li><a href="https://www.benzinga.com/25/03/44280431/cpi-reactions">Inflation Moves In The &#8216;Right Direction&#8217; But Forecast Is Hazy, Economist Says</a></li>
</ul>
Photo: Shutterstock

Equities

Large Cap

Macro Economic Events

Broad U.S. Equity ETFs

Econ #s

Economics

Tech

$BTC

SPDR Dow Jones Industrial Average ETF Trust

INTC

NVDA

PLTR

TSLA

Wall Street Rebounds As Cooling Inflation Draws Tech Dip Buyers: What's Driving Markets Wednesday?

AAOI

ALAB

CDNS

CETX

CRDO

CRNC

DELL

IONQ

MASS

MOBBW

NTNX

NVMI

ONTO

QMCO

RGTI

SHOP

SKYT

TDTH

UBXG

VERX

YAAS

Shares of companies within the broader technology sector are trading higher amid a rebound from weakness earlier this week. The sector may be seeing a boost following softer-than-expected February inflation figures.

LifeSci Capital initiates coverage on Monte Rosa Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLUE#NASDAQ">GLUE</a>) with a Outperform rating and announces Price Target of $19.

Initiation

GLUE

LifeSci Capital Initiates Coverage On Monte Rosa Therapeutics with Outperform Rating, Announces Price Target of $19

Deep-pocketed investors have adopted a bearish approach towards Cava Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAVA#NYSE">CAVA</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in CAVA usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 10 extraordinary options activities for Cava Group. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 10% leaning bullish and 90% bearish. Among these notable options, 7 are puts, totaling $369,818, and 3 are calls, amounting to $128,840.
<h3>What's The Price Target?</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $60.0 to $130.0 for Cava Group over the last 3 months. 
<h3>Volume &amp; Open Interest Development</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Cava Group's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Cava Group's whale activity within a strike price range from $60.0 to $130.0 in the last 30 days. 
<h3>Cava Group 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1741802559_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>CAVA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$7.15</td>
<td>$7.1</td>
<td>$7.15</td>
<td>$60.00</td>
<td>$112.9K</td>
<td align="right">450</td>
<td align="right">0</td>
</tr>
<tr>
<td>CAVA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>07/18/25</td>
<td>$9.55</td>
<td>$9.5</td>
<td>$9.5</td>
<td>$90.00</td>
<td>$74.1K</td>
<td align="right">155</td>
<td align="right">126</td>
</tr>
<tr>
<td>CAVA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$7.15</td>
<td>$7.1</td>
<td>$7.15</td>
<td>$60.00</td>
<td>$73.6K</td>
<td align="right">450</td>
<td align="right">165</td>
</tr>
<tr>
<td>CAVA</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>07/18/25</td>
<td>$49.7</td>
<td>$48.2</td>
<td>$49.4</td>
<td>$130.00</td>
<td>$54.3K</td>
<td align="right">113</td>
<td align="right">4</td>
</tr>
<tr>
<td>CAVA</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>10/17/25</td>
<td>$17.0</td>
<td>$16.85</td>
<td>$17.0</td>
<td>$85.00</td>
<td>$42.5K</td>
<td align="right">156</td>
<td align="right">27</td>
</tr>
</tbody>
</table>

<h3>About Cava Group</h3>
Cava Group Inc owns and operates a chain of restaurants. It is the category-defining Mediterranean fast-casual restaurant brand, bringing together healthful food and bold, satisfying flavors at scale. The company's dips, spreads, and dressings are centrally produced and sold in grocery stores. The company's operations are conducted as two reportable segments: CAVA and Zoes Kitchen. The company generates all of its revenue from the CAVA segment.
After a thorough review of the options trading surrounding Cava Group, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Where Is Cava Group Standing Right Now?</h3>
<ul>
<li>With a trading volume of 1,212,683, the price of CAVA is up by 1.24%, reaching $81.0.</li>
<li>Current RSI values indicate that the stock is may be oversold.</li>
<li>Next earnings report is scheduled for 76 days from now.</li>
</ul>
<h3>What The Experts Say On Cava Group</h3>
In the last month, 5 experts released ratings on this stock with an average target price of $124.8.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; Consistent in their evaluation, an analyst from TD Securities keeps a Buy rating on Cava Group with a target price of $130. 
&#x2A; An analyst from Barclays has decided to maintain their Equal-Weight rating on Cava Group, which currently sits at a price target of $104. 
&#x2A; An analyst from Wedbush downgraded its action to Outperform with a price target of $150. 
&#x2A; Consistent in their evaluation, an analyst from Loop Capital keeps a Hold rating on Cava Group with a target price of $100. 
&#x2A; An analyst from Citigroup has decided to maintain their Neutral rating on Cava Group, which currently sits at a price target of $140. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Cava Group options trades with real-time alerts from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.

Options

Markets

CAVA

What the Options Market Tells Us About Cava Group

Deep-pocketed investors have adopted a bullish approach towards Amgen (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMGN#NASDAQ">AMGN</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in AMGN usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 10 extraordinary options activities for Amgen. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 70% leaning bullish and 20% bearish. Among these notable options, 5 are puts, totaling $244,892, and 5 are calls, amounting to $666,670.
<h3>Predicted Price Range</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $300.0 to $400.0 for Amgen during the past quarter. 
<h3>Volume &amp; Open Interest Development</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Amgen's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Amgen's significant trades, within a strike price range of $300.0 to $400.0, over the past month.
<h3>Amgen 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1741802552_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>AMGN</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$0.88</td>
<td>$0.2</td>
<td>$0.83</td>
<td>$400.00</td>
<td>$466.2K</td>
<td>6.1K</td>
<td>6.0K</td>
</tr>
<tr>
<td>AMGN</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/20/26</td>
<td>$39.8</td>
<td>$38.9</td>
<td>$39.77</td>
<td>$310.00</td>
<td>$79.3K</td>
<td>11</td>
<td>21</td>
</tr>
<tr>
<td>AMGN</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>03/14/25</td>
<td>$5.6</td>
<td>$5.05</td>
<td>$5.5</td>
<td>$315.00</td>
<td>$68.7K</td>
<td>884</td>
<td>132</td>
</tr>
<tr>
<td>AMGN</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$26.0</td>
<td>$25.85</td>
<td>$25.85</td>
<td>$320.00</td>
<td>$62.0K</td>
<td>192</td>
<td>65</td>
</tr>
<tr>
<td>AMGN</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/14/25</td>
<td>$2.92</td>
<td>$2.76</td>
<td>$2.76</td>
<td>$310.00</td>
<td>$55.2K</td>
<td>388</td>
<td>320</td>
</tr>
</tbody>
</table>

<h3>About Amgen</h3>
Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drugs Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx Pharmaceuticals bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). The 2023 Horizon acquisition brought several rare-disease drugs, including thyroid eye disease drug Tepezza. Amgen also has a growing biosimilar portfolio.
<h3>Present Market Standing of Amgen</h3>
<ul>
<li>With a volume of 1,655,254, the price of AMGN is down -1.14% at $315.26. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 50 days.</li>
</ul>
<h3>What Analysts Are Saying About Amgen</h3>
A total of 1 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $294.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; Maintaining their stance, an analyst from B of A Securities continues to hold a Underperform rating for Amgen, targeting a price of $294. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Amgen options trades with real-time alerts from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.

AMGN

Amgen's Options: A Look at What the Big Money is Thinking

Deep-pocketed investors have adopted a bearish approach towards Kenvue (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KVUE#NYSE">KVUE</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in KVUE usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 10 extraordinary options activities for Kenvue. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 20% leaning bullish and 60% bearish. Among these notable options, 3 are puts, totaling $139,421, and 7 are calls, amounting to $1,407,967.
<h3>Predicted Price Range</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $20.0 to $23.5 for Kenvue over the last 3 months. 
<h3>Analyzing Volume &amp; Open Interest</h3>
In today's trading context, the average open interest for options of Kenvue stands at 2265.0, with a total volume reaching 38,534.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Kenvue, situated within the strike price corridor from $20.0 to $23.5, throughout the last 30 days.
<h3>Kenvue Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1741802545_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>KVUE</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>05/16/25</td>
<td>$1.3</td>
<td>$1.23</td>
<td>$1.27</td>
<td>$23.00</td>
<td>$704.8K</td>
<td>1.0K</td>
<td>11.0K</td>
</tr>
<tr>
<td>KVUE</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>05/16/25</td>
<td>$1.25</td>
<td>$1.23</td>
<td>$1.23</td>
<td>$23.00</td>
<td>$305.7K</td>
<td>1.0K</td>
<td>3.8K</td>
</tr>
<tr>
<td>KVUE</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>05/16/25</td>
<td>$1.21</td>
<td>$1.18</td>
<td>$1.21</td>
<td>$23.00</td>
<td>$152.4K</td>
<td>1.0K</td>
<td>1.3K</td>
</tr>
<tr>
<td>KVUE</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>05/16/25</td>
<td>$1.29</td>
<td>$1.27</td>
<td>$1.27</td>
<td>$23.00</td>
<td>$84.0K</td>
<td>1.0K</td>
<td>4.4K</td>
</tr>
<tr>
<td>KVUE</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>09/19/25</td>
<td>$3.9</td>
<td>$3.8</td>
<td>$3.8</td>
<td>$20.00</td>
<td>$66.5K</td>
<td>190</td>
<td>20</td>
</tr>
</tbody>
</table>

<h3>About Kenvue</h3>
Kenvue is the world's largest pure-play consumer health company by sales, generating $15 billion in annual revenue. Formerly known as Johnson &amp; Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of silos within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Despite playing in a fragmented industry with intense competition and changing consumer preferences, many of Kenvue's brands are the global leader in their respective segment thanks to their strong brand power.
After a thorough review of the options trading surrounding Kenvue, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Present Market Standing of Kenvue</h3>
<ul>
<li>Trading volume stands at 5,028,386, with KVUE's price down by -1.6%, positioned at $23.11.</li>
<li>RSI indicators show the stock to be may be approaching overbought.</li>
<li>Earnings announcement expected in 55 days.</li>
</ul>
<h3>What Analysts Are Saying About Kenvue</h3>
In the last month, 2 experts released ratings on this stock with an average target price of $28.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; Consistent in their evaluation, an analyst from Canaccord Genuity keeps a Buy rating on Kenvue with a target price of $29. 
&#x2A; Consistent in their evaluation, an analyst from Piper Sandler keeps a Overweight rating on Kenvue with a target price of $27. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Kenvue, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.

KVUE

Behind the Scenes of Kenvue's Latest Options Trends

ABTS

AMOD

APPS

BLBX

BLND

DUOT

FICO

LPSN

PCOR

QBTS

QUBT

SOUN

ZENA

Shares of software companies are trading higher as the tech sector rebounds from weakness earlier this week. The sector may be seeing a boost after a report suggested TSMC pitched a joint venture with several chip designers to operate Intel's factories.

Jefferies analyst Omar Nokta maintains Navigator Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVGS#NYSE">NVGS</a>) with a Buy and maintains $20 price target.

NVGS

Jefferies Maintains Buy on Navigator Holdings, Maintains $20 Price Target

<a href="https://www.bloomberg.com/news/articles/2025-03-12/mexico-holds-off-tariff-retaliation-as-sheinbaum-bets-on-us-deal" title="https://www.bloomberg.com/news/articles/2025-03-12/mexico-holds-off-tariff-retaliation-as-sheinbaum-bets-on-us-deal">https://www.bloomberg.com/news/articles/2025-03-12/mexico-holds-off-tariff-retaliation-as-sheinbaum-bets-on-us-deal</a>

Mexico Delays Its Response To U.S. Tariffs On Steel And Aluminum Imports As President Claudia Sheinbaum Avoids Retaliation While Both Countries Negotiate To Avert Levies On A Wide Range Of Products And Services-Bloomberg

Press Releases

Ivanhoe Electric and Saudi Arabian Mining Company Ma'aden Complete First Full Quarter of Exploration Activities in Saudi Arabia

Ivanhoe Electric Announces Exploration Alliance with BHP to Accelerate the Search for Copper and Other Critical Minerals in the United States

Ivanhoe Electric Announces Multi-Year Sponsorship with the Native American Mining and Energy Sovereignty Initiative (NAMES) through Colorado School of Mines

Ivanhoe Electric Announces Selection of Fluor Enterprises Inc. as the Principal Lead for the Santa Cruz Copper Project Preliminary Feasibility Study

Ivanhoe Electric Clarifies Certain Misleading Media Headlines Regarding Its Recent Registration Statement Filing

Global Copper Market Expected to Reach $548 Billion By 2034 as Bullish Sentiment is Projected Long Term

Ivanhoe Electric Secures 100% Ownership of Mineral Rights at its Santa Cruz Copper Project with Final Option Payment

Ivanhoe Electric and Ma'aden Joint Venture Commences Drilling Activities in Saudi Arabia

General

Brixton Metals Provides Results from Ivanhoe Electric's 2024 Drilling at the Hog Heaven Project, Montana, USA

XtremeX Mining Technology Announces Plans for First Deployment of Its Revolutionary Mineral Drilling Rig with Ivanhoe Electric Following an $11M Series-A Financing Led by GoGreen Partners

BBBXF

CPFXF

TSX:IE

TSX:PD

TSX:WRN

TSXV:BBB

TSXV:CUU

American Battery Technology Company - Common Stock

American Battery Tech

BHP Group Limited American Depositary Shares (Each representing two Ordinary Shares)

Comments

Ivanhoe Electric

Ivanhoe Electric (IE) オプション

Ivanhoe Electric (AMEX:IE) 株価情報, オプションチェーン

ニュース

パートナーシップ

ベンジンガ・グローバル